Taking into account the above-mentioned effects, and also that systemic oxidative stress, which is reported to possess a negative impact on lipids, proteins and endothelial function [115], is decreased by 2-AG [116], inhibiting MAGL may prove a useful strategy for the treatment of obesity and its comorbidities. This evidence concerns the gene MGLL and obesity disorder.